Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q4	-- / 414.065B	--
Feb 4, 2025	2025/Q3	-- / 448.790B	--
Oct 30, 2024	2025/Q2	462.497B / 425.282B	--
Aug 1, 2024	2025/Q1	473.124B / 411.415B	--
Apr 25, 2024	2024/Q4	414.602B / 381.093B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q4-- / 414.065B--

Feb 4, 20252025/Q3-- / 448.790B--

Oct 30, 20242025/Q2462.497B / 425.282B--

Aug 1, 20242025/Q1473.124B / 411.415B--

Apr 25, 20242024/Q4414.602B / 381.093B--

Unlock Free Earnings Estimates

Open Account

Astellas Pharma: Confirmation letter

Nov 5, 2024 23:52 ET

Astellas Pharma: Half Year Report - Term 20 (2024/04/01 - 2025/03/31)

Nov 5, 2024 23:51 ET

Astellas Pharma: Supplementary financial information for the 2nd quarter (interim period) of the fiscal year ending March 31, 2025

Oct 30, 2024 02:00 ET

Astellas Pharma: Financial results briefing materials for the 2nd quarter (interim period) of the fiscal year ending March 31, 2025

Oct 30, 2024 02:00 ET

Symbol Price % Chg

See the daily top gainer.

Analysis

Updated: Jan 13, 2025

Buy

No Data